Huntington's disease (HD) involves marked early neurodegeneration in the striatum, whereas the cerebellum is relatively spared despite the ubiquitous expression of full-length mutant huntingtin, implying that inherent tissue-specific differences determine susceptibility to the HD CAG mutation. To understand this tissue specificity, we compared early mutant huntingtin-induced gene expression changes in striatum to those in cerebellum in young Hdh CAG knock-in mice, prior to onset of evident pathological alterations. Endogenous levels of full-length mutant huntingtin caused qualitatively similar, but quantitatively different gene expression changes in the two brain regions. Importantly, the quantitatively different responses in the striatum and cerebellum in mutant mice were well accounted for by the intrinsic molecular differences in gene expression between the striatum and cerebellum in wild-type animals. Tissue-specific gene expression changes in response to the HD mutation, therefore, appear to reflect the different inherent capacities of these tissues to buffer qualitatively similar effects of mutant huntingtin. These findings highlight a role for intrinsic quantitative tissue differences in contributing to HD pathogenesis, and likely to other neurodegenerative disorders exhibiting tissue-specificity, thereby guiding the search for effective therapeutic interventions.
INTRODUCTION
The selective susceptibility of certain tissues or cell-types is a prominent feature of neurodegenerative diseases. For example, hippocampus and substantia nigra are selectively affected in Alzheimer's disease and Parkinson's disease, respectively, while Huntington's disease (HD) features the graded loss of medium size spiny neurons in the striatum. HD is a monogenic disorder caused in all cases by an expansion mutation in a CAG repeat that encodes a polyglutamine tract within the large huntingtin protein; a repeat of 36 or more CAGs is associated with characteristic HD symptoms (1 -3) . Early in the disorder, the full-length mutant huntingtin preferentially affects the striatum, while other brain regions, such as cerebellum, are relatively spared, despite expression of comparable and sometimes higher levels of the mutant protein (4) (5) .
Thus, the specificity of neurodegeneration in the HD brain is apparently not due to differential expression of mutant huntingtin.
One attractive hypothesis with profound implications for developing therapeutic interventions is that the effect of mutant huntingtin is qualitatively different in different tissues, e.g. mutant huntingtin targets a process specific to the striatum and not present in cerebellum. To test this hypothesis, we investigated the molecular response to the huntingtin CAG expansion mutation using Hdh CAG knock-in mice (6) . These mice carry genetically precise replicas of the HD CAG mutation in the mouse Htt gene (6) , and exhibit dominantly inherited CAG length-dependent cellular phenotypes, such as striatal-specific dark neuron degeneration and gait deficit (7) . As these mice express full-length mutant huntingtin at endogenous levels from the native promotor at the Htt locus, * To whom correspondence should be addressed. Tel: +1 6176439714; Fax: +1 6177265735; Email: jlee51@partners.org # The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com Human Molecular Genetics, 2011, Vol. 20, No. 21 4258-4267 doi:10.1093/hmg/ddr355 Advance Access published on August 12, 2011 they provide a means to assess the same initial genetic insult that causes human HD. In this study, using Hdh CAG knock-in mice, we specifically tested whether endogenous levels of full-length mutant huntingtin may generate qualitatively different changes in different brain regions by comparing mutant huntingtin-induced gene expression changes in the striatum to those in cerebellum.
RESULTS
The striatum and cerebellum of Hdh Q111/Q111 CAG knock-in mice (expressing full-length huntingtin with 111-glutamines) and wild-type Hdh Q7/Q7 mice (expressing full-length huntingtin with 7-glutamines) were used for microarray gene expression profiling experiments in order to identify early tissuespecific molecular changes that result from endogenous levels of full-length mutant huntingtin at young age (3 -10 weeks) (Supplementary Material, Table S1 ), prior to any changes in tissue architecture and cell-type composition caused by the neurodegenerative process.
Htt mRNA levels and cell-type marker genes in Hdh CAG knock-in mice
In order to determine whether mRNA expression from the wild-type Htt alleles and the Htt CAG knock-in alleles in wildtype and Htt CAG homozygote knock-in mice, respectively, were or were not similar, we examined the expression levels of Htt mRNA determined by four different microarray probes in the Affymetrix MG430 2.0 array (Supplementary Material, Fig. S1 ). As shown in Figure 1 , knock-in mice expressed similar Htt mRNA levels in both the striatum and cerebellum, when compared with the levels in wild-type mice (false discovery rate q-value .0.05). Interestingly, Htt mRNA levels determined by different microarray probes showed different patterns in the striatum and cerebellum. Whether or not tissue-specific Htt mRNA splicing was responsible for this phenomenon remains to be investigated.
Next, we investigated whether the expression data suggested any pathological alterations in brain tissues of young knock-in mice by examining expression levels of canonical marker genes for neurons or astrocytes. As shown in Figure 2A , expression of individual genes that are known to be expressed in either astrocytes or neurons exhibited similar levels in knock-in and wild-type striatum at this stage. Similarly, expression levels of these marker genes in wild-type cerebellum were similar to those of knock-in cerebellum (Fig. 2B ). In addition, the expression levels of these cell-type marker genes did not distinguish knock-in tissues from wild-type tissues in principal components analysis (PCA) ( Fig. 2C and  D; Supplementary Material, Fig. S2 ). These results, therefore, confirmed that Hdh CAG knock-in mouse tissue exhibited similar levels of Htt mRNA as wild-type mouse tissues, and that the brain tissues from the Hdh CAG knock-in mice used in our study did not exhibit changes in neuronal cell or glial cell markers. These results demonstrate that at the ages used, the Hdh CAG knock-in mouse tissues did not show molecular evidence of overt neuronal cell loss or gliotic response, which onset late in life in old Hdh CAG knock-in mice. Thus, we proceeded to conduct microarray gene expression analyses using wild-type and knock-in mice at ages where we did not detect differences in Htt allele expression or in the molecular composition of the brain regions, at least as reflected by neuronal or glial cell markers.
Qualitatively similar gene expression changes in response to full-length mutant huntingtin in striatum and cerebellum
We next identified the genes significantly altered by mutant huntingtin (false discovery rate q-value , 0.05). Overall, 350 probes were significantly altered by mutant huntingtin in striatum (increase, 111; decrease, 239; Supplementary Material, Table S2 ). Only one probe, representing Nudt19, was significantly altered in the cerebellum analysis (3.56-fold decrease in knock-in cerebellum; q-value, 0.0202987). Notably, Nudt19 was also the most significantly altered gene in the striatal analysis (3.27-fold decrease in knock-in striatum; q-value, 4.2E26). Overall, genes significant in the striatum analysis are involved in diverse biological processes, such as transcription, RNA metabolism, energy metabolism, cell cycle and adhesion (Supplementary Material, Table S2 ).
Interestingly, although gene expression changes in mutant cerebellum were not robust compared with those in striatum, deeper analysis revealed that mutant huntingtin may affect the expression of a similar cadre of genes in both tissues. First, for those probes that showed significant differences in mutant striatum ('striatum-significant' probes), comparison of the corresponding fold-changes in the striatum and cerebellum analyses revealed a high concordance rate (78.8%; Fig. 3A ), unlikely to be observed by chance (Fig. 3B) . Secondly, in PCA, the striatum-significant probes clearly distinguished the mutant cerebella from the wild-type cerebella (Fig. 3C) , and, conversely, the top 100 probes that were influential in discriminating mutant cerebella from wild-type cerebella also distinguished the mutant striata from the wild-type striata (Fig. 3D) . Lastly, in gene set enrichment analysis (GSEA), the significantly altered probes in mutant striatum were also significantly enriched in mutant cerebellum (Fig. 4) . Thus, in contrast to our initial hypothesis, these observations suggested that mutant huntingtin results in qualitatively similar gene expression changes in the mouse counterparts of both the primary target tissue of HD and a region relatively spared in the human disease.
Alteration of similar pathways in striatum and cerebellum of knock-in mice Our initial hypothesis was further evaluated at the pathway level by comparing the pathways significantly enriched by mutant huntingtin in striatum to those in cerebellum. In total, 205 and 34 pathways were significantly enriched in mutant striatum and mutant cerebellum, respectively ( Fig. 5A ; Supplementary Material, Tables S3 and S4). Consistent with a high degree of sharing, 14 pathways were enriched significantly in both tissues; lipid/sterol metabolism ( Fig. 5A  and B Table S3 ). Next, we performed an overall statistical comparison to determine whether qualitatively similar pathways were affected by mutant huntingtin in striatum and cerebellum. Similar to the results of the probe-level analysis, the directions and magnitudes of striatum-significant pathways (205 pathways) were highly concordant (82.4% concordant) and significantly correlated (Spearman's correlation test P-value, 8.02E215), respectively, with those same pathways in the cerebellum analysis. Similarly, the directions and magnitudes of the cerebellum-significant pathways (34 pathways) were highly concordant (85.3% concordant) and significantly correlated (P-value, 0.00089), respectively, with those same pathways in the striatum analysis. Finally, all 14 pathways that were significantly altered in both brain regions displayed the same directions of enrichment (Supplementary Material, Table S5 ), reinforcing the view that mutant huntingtin induces qualitatively similar gene expression changes in striatum and cerebellum, although in the striatum these changes are of a greater relative magnitude.
Contribution of intrinsic quantitative tissue differences in the tissue-specific responses to mutant huntingtin
Together, these results suggested that the eventual differential neurodegeneration is contributed by quantitative rather than qualitative differences between these two tissues, supporting the alternative hypothesis that mutant huntingtin has similar biological effects in striatum and cerebellum but that these tissues may have inherently different capacities to buffer these effects. This reformulated hypothesis predicts that pathways that are altered significantly in one tissue but not the other in response to mutant huntingtin may be target pathways that are already expressed at different levels in normal striatum and cerebellum. Conversely, pathways that are altered significantly in both tissues due to mutant huntingtin may be expressed at comparable levels in wild-type striatum and cerebellum.
To test these predictions, we identified pathways that were altered by mutant huntingtin in either a tissue-specific or a non-tissue-specific manner to examine the relationships between the tissue specificities of the significant pathways in knock-in mice (i.e. specificity index; see Materials and Methods) and the basal level differences between wild-type striatum and wild-type cerebellum. As shown in Table 1 and Supplementary Material, Figure S3 , 19 pathways were altered by mutant huntingtin in a striatal-specific manner (selectively enriched in mutant striatum; specificity index .5). In the wild-type tissue comparisons, all of these pathways showed a significant inherent tissue-differential, with enrichment in either control cerebellum (18 pathways) or control striatum (1 pathway, cytoplasm organization and biogenesis). These results indicated that the pathways altered by mutant huntingtin in a tissue-specific manner were already differently regulated in wild-type tissues. Many of these pathways significantly altered by mutant huntingtin in an apparent tissuespecific manner were related to energy metabolism. For example, 'ATP synthesis coupled electron transport' was significantly altered by mutant huntingtin only in striatum (specificity index, 7.70), and this same pathway was significantly enriched in wild-type cerebellum compared with wild-type striatum (Table 1 ; Supplementary Material, Fig. S3 ). PCA using probes comprising this pathway (30 probes) confirmed this interpretation (Supplementary Material, Fig. S4A ). In addition, wild-type cerebellum showed significantly increased mitochondrial enzyme citrate synthase activity levels compared with wild-type striatum (Supplementary Material, Fig. S4B ), supporting the idea that 'ATP synthesis coupled . Data bars represent mean + SD. None of the selected marker genes was significantly different from corresponding controls by FDR q-value (q , 0.05). In addition, expression levels of marker genes for oligodendrocytes (i.e. Mbp) and microglia (i.e. Itgam) were not different between knock-in and wild-type tissues. (C) PCA was performed using the striatum expression data of 32 microarray probes representing selected marker genes for neurons and astrocytes. The first two principal components did not separate control striata from mutant striata, indicating that overall expression levels of neuronal and astrocytes marker genes were not different between mutant and control striatum. (D) Similarly, PCA was performed using the cerebellum expression data of 32 microarray probes representing selected marker genes for neurons and astrocytes. PC1, principal component 1; PC2, principal component 2.
electron transport' may be altered selectively in mutant striatum because striatum has an inherently weaker buffering capacity for this pathway compared with cerebellum.
Next, we investigated the subset of 12 pathways that were significantly altered by mutant huntingtin in a non-tissuespecific manner (specificity index ,2). With the exception of one pathway (MHC class I protein complex, nominal enrichment P-value, 0.007), wild-type striatum and wild-type cerebellum showed similar expression levels for all pathways in this category (Table 2 ; Supplementary Material, Fig. S5 ), implying that because striatum and cerebellum may have similar buffering capacities for those pathways, a significant effect of mutant huntingtin is observed in both tissues. Finally, for all pathways significantly altered by mutant huntingtin in either striatum or cerebellum (225 pathways), we observed a significant correlation between the specificity index and the basal level difference (Spearman's rho, 0.42; P-value, 7.92E211), supporting the reformulated hypothesis that intrinsic quantitative differences in pathways between normal tissues contribute to the tissue-specific responses to mutant huntingtin.
Contribution of intrinsic quantitative differences in tissues to the tissue-specific responses to mutant ataxin-1 Interestingly, the two predictions of the reformulated hypothesis were also supported by pathway analysis in a knock-in mouse model of a distinct CAG repeat expansion disorder, spinocerebellar ataxia 1 (SCA1) (8) . SCA1 is caused by CAG trinucleotide repeat expansion in ATXN1, and wide-spread expression of mutant ataxin-1 preferentially causes neurodegeneration in cerebellum, with relative sparing of neurons in the forebrain (9 -10). Our reformulated hypothesis predicted that (i) pathways significantly altered in SCA1 knock-in To test significance of the concordance rate of striatum-significant probes, a null distribution of concordance rates was generated by randomly sampling 350 probes from our data 10 000 times. The concordance rates (X-axis) of randomly selected probes centered around 46.7% (mean), and the true concordance rate observed in striatum-significant probes (78.8%, red triangle) significantly deviated from the null distribution (goodness-of-fit test, P-value , 2.2E216). (C) PCA using striatal significant probes in cerebellum. Gene expression levels in the cerebellum for the striatum-significant probes (350 probes) were used for PCA to examine their predictive value in distinguishing wild-type and mutant cerebellum. Open blue circle and filled blue circle represent wild-type and knock-in cerebellum, respectively. Combination of PC1 and PC2 separated knock-in cerebellum from wild-type cerebellum. (D) PCA using cerebellum influential probes in striatum. Similarly, expression levels of probes that were influential in discriminating knock-in cerebellum from wild-type cerebellum (100 probes) were used for subsequent PCA to determine whether probes that could distinguish knock-in cerebellum from wild-type cerebellum also separate knock-in striatum from wild-type striatum. Open red circle and filled red circle represent wild-type and knock-in striatum, respectively. PC2 separated knock-in striatum from wild-type striatum. A cluster of five samples in the left and the other cluster of seven samples in the right are females and males, respectively.
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mice in a tissue-specific manner would show differential expression levels between the wild-type tissues, and (ii) pathways significantly altered in a non-tissue-specific manner would show similar expression levels between wild-type tissues. We performed pathway analysis of the publicly available SCA1 knock-in mouse gene expression data (GSE2867) for cerebellum and forebrain tissue, identifying 171 and 37 significantly enriched pathways (q , 0.01), respectively, with 23 pathways shared (Supplementary Material, Tables  S6-S8 ). Among these, five pathways were significantly altered by mutant ataxin-1 in a tissue-specific manner (specificity index .5, significant only in cerebellum), and, as predicted by our hypothesis, the wild-type cerebellum showed significantly decreased expression levels for those pathways compared with wild-type forebrain (Supplementary Material, Fig. S6 ). In contrast, wild-type cerebellum and forebrain showed similar expression levels for the pathways that were altered by mutant ataxin-1 in a non-tissue-specific manner (five pathways, specificity index ,2) (Supplementary Material, Fig. S7 ). The results of these analyses, therefore, confirmed the key predictions of the hypothesis, and support an important role for intrinsic quantitative characteristics of the individual tissues in determining the tissue specificity of pathogenesis in response to the SCA1 mutation. In addition, our results implied that this molecular mechanism may contribute to selective pathogenesis in other neurodegenerative disorders.
DISCUSSION
Using relevant animal models has become one of the mainstays of efforts to investigate and understand the pathogenic processes leading to the overt clinical symptoms that define human diseases. Although numerous mouse microarray gene expression studies have been performed to study HD, most of them used transgenic models of HD where both CAG repeat expansion and increased mutant huntingtin levels contribute to altering expression of genes. Since human HD is a disease of CAG repeat length where the full-length protein is expressed at normal physiological levels throughout life prior to diagnosis and the rate of pathogenesis leading to onset of diagnostic symptoms in humans is not altered by increased gene dosage, we reasoned that knock-in mouse models that express the mutant protein from the endogenous Htt gene represent the best comparison to human HD for early effects of the mutation on gene expression. Therefore, in order to identify early events leading to pathogenesis and to understand the molecular basis of the differential response of various brain regions to the HD CAG repeat mutation, we used Hdh CAG knock-in mice, which express CAG expanded Htt mRNA at a level comparable with wild-type Htt mRNA in wild-type control mice ( Fig. 1) . At the young ages examined, these mice did not show signs of overt pathological changes in striatum and cerebellum, arguing against the mutant huntingtin-induced gene expression changes being secondary to gliosis or neuronal cell death. Rather, the genes and pathways that we have identified represent molecular changes closely associated with the presence of mutant huntingtin, providing clues to the primary effects of the 'gain-of-function' conferred on huntingtin by the expanded polyglutamine tract. Thus, these early gene expression changes are good candidates for (i) the investigation of early steps in the mechanism by which mutant huntingtin leads eventually to neuronal cell death and (ii) the development of treatments effective prior to evident cellular pathology. In addition, our results have revealed that, despite the dissimilar neurodegenerative responses characteristic of striatum and cerebellum in HD, the endogenous level of full-length mutant huntingtin altered the expression of similar genes and pathways in the mouse striatum and cerebellum, suggesting that the direct effects of mutant huntingtin may be tissuecontext independent. Indeed, changes in many biological processes detected in HD brains have also been observed in non-neuronal cells (11) (12) (13) (14) (15) (16) (17) (18) , consistent with the view that a biochemical impact of the HD mutation is felt in all tissues, Figure 4 . Significantly altered probes in knock-in striatum were enriched in knock-in cerebellum. (A) GSEA was performed to test whether significantly increased probes in mutant striatum (111 probes as a set) were significantly enriched in the increased probes of the cerebellum analysis using phenotype permutation (1000). (B) Similarly, we tested whether significantly decreased probes in mutant striatum were significantly enriched among the decreased probes of cerebellum analysis. NES, normalized enrichment score. Top panel shows running-sum statistics (Y-axis) and rank ordered probes (X-axis). The rank-sum statistics that showed maximum deviation from zero was defined as enrichment score. Middle panel shows locations of gene set probes (Hits) in the rank ordered data (X-axis). Bottom panel shows ranking metric (signal to noise ratio; Y-axis) and rank of each probe (X-axis).
Human Molecular Genetics, 2011, Vol. 20, No. 21 4263 but that it produces pathogenic changes in a tissue-specific manner because of inherent quantitative differences in the physiology of different tissues. The striatum may be more susceptible to mutant huntingtin not because mutant huntingtin targets a process specific to the striatum but rather because this tissue may have a relatively lower capacity to maintain the integrity of the pathways disturbed by mutant huntingtin. In this model, the sets of genes underlying fundamental biochemical processes are all expressed in both tissues, but at different relative levels, depending on the role of each process in the function and maintenance of the respective tissue. Mutant huntingtin would then represent a toxic insult that acts by disrupting one or more critical biochemical processes, with a resultant cascade of effects that lead to eventual cell death. The tissue that has the greater inherent capacity in the presence of mutant huntingtin to continue to carry out the critical target process(es) and/or to minimize the downstream consequences would then be relatively more resistant to its toxic effects. Consequently, our data suggest that full-length mutant huntingtin targets the same biochemical process(es) in both striatum and cerebellum, but that striatum has less inherent capacity to carry out the critical process(es) or to mitigate its consequences and is therefore more susceptible to neuronal loss in HD. As an illustrative analogy, we model the HD tissue specificity using hand drills (i.e. mutant full-length huntingtin) and buckets (i.e. pathways) (Fig. 6 ). In this model, a hand drill makes holes in both the energy metabolism bucket and the lipid/cholesterol metabolism bucket in both the striatum and cerebellum. Due to the inherently different sizes of the energy metabolism buckets in striatum and cerebellum, the energy metabolism bucket in striatum will drain faster than energy metabolism bucket in cerebellum. In contrast, in this analogy, the lipid/cholesterol metabolism buckets will drain similarly because the sizes of buckets are similar. As a result, a hand drill results in less pronounced effects on the energy metabolism bucket in cerebellum at early time points. This analogy, based on our data, highlights the possibility that the intrinsic quantitative characteristics of tissues may significantly modulate the degree to which mutant fulllength huntingtin toxicity becomes manifest. Our findings are consistent with the observation that neurodegenerative changes in polyglutamine disorders become less tissue specific as the CAG expansion increases into the juvenile onset size range, representing a qualitatively similar but quantitatively greater toxic insult. In addition, as the alterations identified represent early consequences of the HD Figure 5 . Pathways significantly enriched due to mutant huntingtin. (A) Pathways significantly enriched due to mutant huntingtin were manually grouped into broad categories, and the proportion of each category relative to the total number of significant pathways was plotted. (B) Six pathways related to lipid/sterol metabolism were significant in the cerebellum analysis and five of them were also significant in the striatum analysis, suggesting that striatum and cerebellum show a similar alteration of lipid/sterol homeostasis caused by mutant huntingtin. (C) Seven pathways associated with energy metabolism were significantly enriched only in the striatum analysis, implying that mutant huntingtin-mediated dysregulation of energy metabolism is prominent only in striatum. Red, blue and yellow represent pathway significantly enriched in knock-in striatum, knock-in cerebellum and both, respectively.
4264
CAG expansion mutation, the distinction between those pathways that are more robustly affected in the striatum and those altered similarly across tissues offers a novel approach to prioritizing processes likely to harbor candidate therapeutic targets for HD. Importantly, these findings also indicate that these target processes can potentially also be investigated in systems that may be more tractable than striatal neurons in order to understand the tissue factors that confer relative protection from toxicity. The strategy outlined here can, in principle, be applied to any human disease that shows tissue specificity to implicate qualitative or quantitative tissue differences and provides a new way of uncovering disease mechanisms, rooted in understanding of disease processes in the context of the inherent normal physiology of particular cells and tissues.
MATERIALS AND METHODS

Microarray gene expression profiling
Male and female homozygote Hdh CAG knock-in mice (Hdh Q111/Q111 ), expressing full-length huntingtin with 111-glutamine repeats from endogenous targeted alleles and wild-type littermate mice, expressing 7-glutamine full-length huntingtin from the endogenous alleles, generated in heterozygous Hdh Q111 /Hdh Q7 mating (CD1 background, 3 -10 weeks, six mice per group, mixed gender), were used for microarray gene expression profiling experiments. Total RNA was extracted from striatum and cerebellum (Trizol reagent). Total RNA was purified (Qiagen, RNeasy mini column) for cDNA/cRNA synthesis (SuperScript and Enzo kit), and labeled cRNA was hybridized on Affymetrix MG430 2.0 arrays. All microarrays were background corrected and normalized by gcRMA (R, 2.7.2; gcrma, 2.12.1), and batch effects were corrected (Supplementary Material, Table S1 ) (19) . Significantly altered probes were identified by false discovery rate (q , 0.05) as described previously (20) . Sex and age of mice were not used as covariates in the initial probelevel analysis. Since only one probe was significant in cerebellum analysis, we identified top 100 probes that were influential in discriminating knock-in cerebellum from wild-type cerebellum based on bootstrapping-coupled modeling using partial least square (pdmclass, 1.12) for subsequent PCA (Fig. 3D ). All microarray data were submitted to the Gene Expression Omnibus (GEO) (accession number, GSE9038). All animal experiments were performed to minimize pain and discomfort, under an approved protocol of the Massachusetts General Hospital Subcomittee on Research Animal Care (SRAC; protocol number, 2009N000216).
SCA1 microarray data
To test the predictions of our reformulated hypothesis, we evaluated whether intrinsic tissue differences may contribute to the tissue-specific response in a knock-in mouse model of a distinct CAG repeat expansion disorder, SCA1. SCA1 knock-in mouse cerebellum and forebrain microarray data were obtained from the GEO (GSE2867). This data series had 20 samples of SCA1 knock-in mice with 154 CAG repeats in the mouse Sca1 locus and corresponding controls (12 samples at 4 weeks and 8 samples at 12 weeks). Expression values were normalized by gcRMA (R, 2.7.2; gcrma, 2.12.1). We primarily used 4-week data, which had three biological replicates. Since the small sample size of this data set did not allow enough phenotype permutations, we only performed gene set permutation to identify significantly altered pathways (q-value , 0.01). Nineteen pathways were significantly enriched in a tissue-specific manner. These pathways had specificity index greater than 5. Enrichment P-value represents P-value obtained from permutation-based enrichment analysis comparing wild-type striatum with wild-type cerebellum for a given pathway. Twelve pathways were significantly enriched in a non-tissue-specific manner. These pathways had specificity index smaller than 2. Enrichment P-value represents nominal P-value obtained from permutation-based enrichment analysis comparing wild-type striatum with wild-type cerebellum for a given pathway.
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Gene set enrichment analysis
To specifically test whether significantly altered probes in mutant striatum were enriched in mutant cerebellum (GSEA), custom gene sets were built using probes significantly increased or decreased in mutant striatum for GSEA (1000 phenotype permutations) (21) . The signal-to-noise ratio was used to rank probes for the GSEA. For general identification of significantly enriched pathways in striatum and cerebellum of knock-in mice, pre-compiled gene sets from pathway databases (Biocarta and KEGG) and Gene Ontology were used (R, 2.7.2; sigPathway, 1.8.0) (22) . All gene set enrichment analyses were based on individual probes. Since the size of gene set influences the permutation-based enrichment statistics, gene sets with size between 25 and 500 were used (22) . Significantly enriched gene sets in Hdh CAG knock-in tissues were identified by gene set permutation (10 000) and phenotype permutation (1000) false discovery rate (q , 0.05) (22) . Briefly, the gene set enrichment score (i.e. average of t-values of genes in the given pathway) was compared with a null distribution obtained by permuting data. NTk and NEk stat represent the strength and direction of enrichment of a given pathway determined by gene set and phenotype permutation, respectively. An enriched pathway means that the members of that pathway are significantly clustered at the top (for positive enrichment) or bottom (for negative enrichment) of the ranked data set.
Specificity index and GSEA of control tissues
Specificity index is a measure of tissue selectivity for a given pathway, and was calculated as the absolute difference between the absolute NTk gene set statistic value from the striatum sigPathway pathway analysis and absolute NTk gene set statistic value from the cerebellum sigPathway pathway analysis. A high specificity index indicates that the pathway is selectively altered in one tissue. A low specificity index indicates that the pathway is altered in both striatum and cerebellum in a non-tissue-specific manner. We used a specificity index of five or higher to identify pathways that were highly tissue specific in HD knock-in mice. For non-tissue-specific pathways, we selected pathways with a specificity index of two or lower from significantly enriched pathways in both striatum and cerebellum. For selected pathways, we tested statistically whether those pathways were enriched in either wild-type striatum or wild-type cerebellum to understand the relationship between specificity index and the basal level difference of a pathway in normal tissues. For this, we applied a similar GSEA algorithm as the sigPathway program. Briefly, for a given pathway, we calculated t-values of all probes in the pathway by comparing expression levels of wild-type striatum to those of wild-type cerebellum. Then, we divided the sum of t-values of probes by the probe number to calculate a normalized true gene set statistics (i.e. enrichment score). Then, we permuted the data set 10 000 times (gene set permutation) to construct a null distribution of gene set statistics. Based upon the null distribution and the true gene set statistics, we calculated a one-tail P-value for enrichment score, representing the probability of enrichment scores lower (for pathways with negative true gene set statistics) or higher (for pathways with positive true gene set statistics) than random selections. Significances of pathways were determined by nominal P-values. For SCA1 analysis, the same approaches were applied to cerebellum and forebrain data.
Citrate synthase activity assay
To compare mitochondrial activities in tissues, citrate synthase activity, as a marker enzyme for mitochondrial activity, was measured from whole cell extracts (20 mg protein) of striatum and cerebellum of control and Hdh CAG knock-in mice (8 weeks, three biological replicates and three technical replicates) according to the manufacturer's protocol (citrate synthase assay kit, Sigma). Relative citrate synthase activity was calculated by subtracting average of endogenous V max from average of total V max followed by correcting for protein concentration. Figure 6 . An illustrative analogy to explain HD tissue specificity. We model the HD tissue specificity using hand drills (i.e. mutant huntingtin) and buckets with different shapes (i.e. different pathways) and sizes (i.e. different buffering capacities). Among many different types of buckets, a hand drill selectively makes holes of equal size in buckets with two handles in the top panel (i.e. energy metabolism) and buckets with one handle in the bottom panel (i.e. lipid/cholesterol metabolism). Loss of contents because of the hole represents dysregulation of a cellular process. (A) Energy metabolism is used as an example of pathways significantly altered by mutant huntingtin in a tissue-specific manner. Although the hand drill makes holes in both buckets, the smaller bucket drains first because it inherently contains less liquid than the bigger bucket. (B) Lipid/cholesterol metabolism is used as an example of pathways significantly altered in a non-tissue-specific manner by mutant huntingtin. The hand drill makes holes in these buckets, and they drain similarly due to similar bucket sizes. Thus, in these cases, a similar sized hole in all buckets results in differential effects in one circumstance and equal effects in the other circumstance.
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